TY - JOUR
T1 - Lymph node examination among patients with gastric cancer: Variation between departments of pathology and prognostic impact of lymph node ratio
AU - Lemmens, Valery
AU - Dassen, AE
AU - van der Wurff, AAM
AU - Coebergh, Jan Willem
AU - Bosscha, K
PY - 2011
Y1 - 2011
N2 - Introduction: At least 15 lymph nodes should be retrieved for proper TNM-staging in gastric cancer. We evaluated nodal harvest and examined its relation to stage distribution and survival at a population-based level, including the value of N-ratio (metastatic/evaluated) as a staging modality. Methods: All patients resected for primary MO gastric cancer diagnosed in 1999-2007 in the Dutch Eindhoven Cancer Registry area were included (N = 880). Determinants of lymph node evaluation and their relationship with stage and survival were assessed in multivariable regression analyses. N-ratio categories were determined (N-ratio 0, 0%; N-ratio 1, 0.1%-19%; N-ratio 2, 20%-29%; N-ratio 3, >= 30%) Results: The median number of lymph nodes examined was 7, dependent on N-category (NO: 7; N+: 8). It varied between departments of pathology from 5 to 9. This variation remained after adjustment for relevant patient- and tumour factors. Stage distribution differed between pathology departments (proportion NO ranging from 14% to 21%, p = 0.003). Among resected patients with N0M0 disease and <7 nodes examined, 5-year survival was 56%, compared to 69% among patients with >= 7 nodes examined (p = 0.012). Five-year survival for N-ratio 0 was 58%, N-ratio 1 50%, N-ratio 2 18% and N-ratio 3 11% (p < 0.0001), while 5-year survival ranged from 58% for NO, 17% for N1, and 11% for N2/3 (p < 0.0001). Conclusion: In this series of patients with a relatively low number of evaluated lymph nodes, a high prognostic accuracy of N-ratio was found. However, improvement in nodal assessment is mandatory. (C) 2011 Elsevier Ltd. All rights reserved.
AB - Introduction: At least 15 lymph nodes should be retrieved for proper TNM-staging in gastric cancer. We evaluated nodal harvest and examined its relation to stage distribution and survival at a population-based level, including the value of N-ratio (metastatic/evaluated) as a staging modality. Methods: All patients resected for primary MO gastric cancer diagnosed in 1999-2007 in the Dutch Eindhoven Cancer Registry area were included (N = 880). Determinants of lymph node evaluation and their relationship with stage and survival were assessed in multivariable regression analyses. N-ratio categories were determined (N-ratio 0, 0%; N-ratio 1, 0.1%-19%; N-ratio 2, 20%-29%; N-ratio 3, >= 30%) Results: The median number of lymph nodes examined was 7, dependent on N-category (NO: 7; N+: 8). It varied between departments of pathology from 5 to 9. This variation remained after adjustment for relevant patient- and tumour factors. Stage distribution differed between pathology departments (proportion NO ranging from 14% to 21%, p = 0.003). Among resected patients with N0M0 disease and <7 nodes examined, 5-year survival was 56%, compared to 69% among patients with >= 7 nodes examined (p = 0.012). Five-year survival for N-ratio 0 was 58%, N-ratio 1 50%, N-ratio 2 18% and N-ratio 3 11% (p < 0.0001), while 5-year survival ranged from 58% for NO, 17% for N1, and 11% for N2/3 (p < 0.0001). Conclusion: In this series of patients with a relatively low number of evaluated lymph nodes, a high prognostic accuracy of N-ratio was found. However, improvement in nodal assessment is mandatory. (C) 2011 Elsevier Ltd. All rights reserved.
U2 - 10.1016/j.ejso.2011.03.005
DO - 10.1016/j.ejso.2011.03.005
M3 - Article
C2 - 21444177
SN - 0748-7983
VL - 37
SP - 488
EP - 496
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
IS - 6
ER -